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INTRODUCTION:  Atraumatic  splenic  rupture  is a rare  but life-threatening  condition  which  may  be  asso-
ciated  with  hematological  malignancies.
PRESENTATION  OF  CASE:  We  present  the case  of a 63-year-old  male  patient  with  a  history  of  chronic
myelomonocytic  leukemia  and  sarcoidosis  under  therapy  with  prednisone,  who suffered  an  atraumatic
splenic  rupture  with  hemodynamic  instability.  He  was  managed  with proximal  splenic  artery  emboliza-
tion  and  secondary  open  splenectomy.  On  pathology  the  diagnosis  of  peliosis  lienalis  was  established.
DISCUSSION:  Peliosis  is  a rare pathological  entity,  which  presents  with  multiple  blood-filled  cavitiesChronic myelomonocytic leukemia
Spontaneous splenic rupture
Case report
within  parenchymatous  organs  and is of  unknown  etiology  and  pathogenesis.  In  retrospect  a rapid
increase  in  splenomegaly  and  inhomogeneous  parenchyma  of the  spleen  on  sonography  was  realized.
CONCLUSION:  Sonographic  changes  in  size  and  parenchyma  of  the spleen  in patients  with  hematological
malignancies  might  help  suspecting  peliosis  lienalis  with  impending  splenic  rupture  and  could  alter
clinical  management  towards  a  prophylactic  splenectomy.
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1. Introduction
Atraumatic splenic rupture is a rare entity with an esti-
mated median age of 52 years [1]. In a systematic review of
845 patients the most frequent etiological groups were neoplas-
tic, infectious and inflammatory non-infectious disorders [2]. The
authors reported 24 patients with myeloproliferative disorders,
12 with myelodysplastic syndromes and 18 with peliosis lien-
alis as underlying etiologies [2]. Peliosis is a rare pathological
entity, which presents with multiple blood-filled cavities within
parenchymatous organs [3].
We found one case report, which described an 62-year-old
male with an untreated chronic myelomonocytic leukemia (CMML)
who suffered from an atraumatic splenic rupture in the context
of a peliosis lienalis [4]. Our report adds sonographic appear-
ance and dynamic of splenomegaly prior to the splenic rupture
in a patient with CMML  and peliosis lienalis on histopathologi-
cal examination. These novel sonographic findings could influence
clinical management towards a closer observation or a prophylac-
Abbreviations: CMML, chronic myelomonocytic leukemia; WHO, World Health
Organization.
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ic splenectomy. Our patient was  treated in a community hospital
nd the manuscript was  prepared in accordance with the Surgical
Ase REport (SCARE) guidelines [5,6].
. Presentation of case
A 63-year-old white male patient was  brought to our Emergency
epartment by ambulance with a sudden-onset neck pain followed
y two episodes of a collapse at home. He did not report any
ever, abdominal pain or trauma. The patient suffered from CMML-
 (<5% blasts in the bone marrow) without need for treatment.
bdominal sonography performed one-month prior showed a pro-
ressive splenomegaly (from 14 to 16 cm in length within seven
onths, Fig. 1) and a new inhomogeneous splenic parenchyma with
mall hypoechogenic lesions (Fig. 2). On further medical history,
arcoidosis was  known and under treatment with 7.5 mg  of pred-
isone. Due to an atrial fibrillation the patient was  taking apixaban.
The patient presented afebrile with a blood pressure of 78/43
mHg  and a heart rate of 96/min. On examination we found a
allooned abdomen without signs of peritonitis. The computed
omography showed several hypodense lesions within the spleen
nd contrast blushes, which were interpreted as splenic rupture
ith ongoing bleeding (Fig. 3). Emergent diagnostic angiogra-
hy revealed no active bleeding but a large subcapsular splenic
ematoma. A selective embolization was not possible and there-
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. Sonography of the spleen two months prior to the atraumatic-pathological
splenic rupture. Several hypoechogenic small areas were newly present.
fore a proximal splenic artery embolization was performed. Five
days after the embolization an open splenectomy was performed
showing three liters of clotted blood within the abdominal cavity.
Pathology demonstrated a 19 × 14 × 6 cm 890 g spleen with
multiple ruptures of the capsule. The cut surface revealed multiple
well-demarcated round to oval, blood-filled cavities of about 40
cavities of 0.3 mm–3  mm per cm2, evenly distributed throughout
the parenchyma (Fig. 4). They were preferentially located in the
parafollicular zones, adjacent to periarteriolar lymphoid sheaths,
and may  be surrounded by white pulp. They lacked an endothe-
lial lining (Fig. 5). There were no signs of locally bound immune
complexes, leukemic tissue or sarcoidosis.The postoperative course was uneventful and we discharged the
patient after 13 days in hospital. The sonography one year after the
splenectomy showed no signs of a peliosis of the liver. One and a half






ig. 3. Contrast-enhanced axial abdominal computed tomography showing free
uid around the liver and the inhomogeneous splenic parenchyma.
lasts with 16% and therefore a progression to a CMML-2 (defined as
0–19% blasts in the bone marrow) was diagnosed and a treatment
ith azacitidine started. At this point the patient presented with
rthralgias due to the sarcoidosis without any other symptoms.
. Discussion
Peliosis was  first described in the liver in 1861 by Wagner
7]. To describe the appearance of the liver section surface, the
reek word “pelios” was inaugurated, meaning “black-bluish with
uggillation”. The exact etiology is unknown and pathogenesis of
eliosis is speculated to be underlying vascular malformations that
re made apparent by local alterations of vascular pressure [8].
nother hypothesis is a focal cell necrosis that leads to destruction
f the reticulum framework, which allows cyst-formations from the
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Fig. 4. Histological section with multiple evenly distributed blood-filled cavities of
about 0.5 to 3 mm;  and some 40 per cm2.


































follicle with the central artery. Inset: Immunohistochemistry with CD34 antibod-
ies  revealing the absence of an endothelial lining of the blood-filled cavity (arrow
heads).
inflow of blood from adjacent sinusoids [9]. The first description
of peliosis of the spleen was by Cohnheim in 1866 [10]. Asso-
ciations of peliosis were described with hematologic neoplasms
[4,11], cirrhosis [12] or in patients who have been received anabolic
androgenic steroids [13]. But peliosis lienalis is also described with-
out any comorbidities [14]. Gugger and Gebbers reported immune
complexes at the margin of the lesions for the first time in two
patients [15]. One of the women was under long-term treatment
with steroids. However, we could not display any immune com-
plexes although our patient was under a minimal steroid dose. In
our case an association with the CMML  is possible. By the revised
2016 World Health Organization (WHO) classification of myeloid
neoplasms and acute leukemia, CMML  is classified as a clonal
hematopoietic stem cell disorder with features of both myelodys-
plastic or myeloproliferative neoplasms [16]. In a cohort of 373
patients with 2016 WHO-defined CMML  the median patient age
was 71 years with a male dominance of 66% [17]. A palpable
hepato- and/or splenomegaly was frequent (27%), and an isolated
splenomegaly was present in 14%. However, the rate of atrau-
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4,18,19]. A retrospective study of 555 patients with CMML  demon-
trated a 7% rate of splenectomy in the time period from 1980 until
018 [20]. In 8 (21%) patients the indication was a splenic rupture
ith six atraumatic and two traumatic ruptures. Peliosis lienalis as
he cause for an atraumatic rupture in the context of a diagnosed
MML  is even rarer. We  found only one report of a 62-year-old
an  with CMML  and splenomegaly. The 800 g splenectomy speci-
en  showed a large subcapsular hematoma and evenly distributed
−40 mm cyst-like spaces filled with fresh or clotted blood which
ed to the diagnosis of peliosis lienalis [4].
The diagnosis of peliosis lienalis before histopathology is rarely
ossible. However, certain changes within the spleen on sonogra-
hy or computed tomography could rise a suspicion [21]. In our
ase, there was a change noted within the splenic parenchyma a
onth prior to the rupture (Figs. 1 and 2). This sonographic finding
ogether with a progressive splenomegaly in patients with CMML
ave not been published before and we believe that this could alter
he management of these patients towards more frequent obser-
ation or prophylactic splenectomy.
. Conclusion
In conclusion, we  would like to stress the differential diagnosis
f peliosis lienalis in patients with atraumatic splenic rupture. A
rogression of splenomegaly with inhomogeneous parenchyma on
onography in patients with hematological malignancies could be
n early hint of a peliosis lienalis with impending rupture.
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